Empty Virions In AAV8 Vector Preparations Reduce Transduction Efficiency And May Cause Total Viral Particle Dose-Limiting Side-Effects
about
Development of Patient-specific AAV Vectors After Neutralizing Antibody Selection for Enhanced Muscle Gene TransferCell-Mediated Immunity to AAV Vectors, Evolving Concepts and Potential Solutions.Strategies to circumvent humoral immunity to adeno-associated viral vectors.Advanced Characterization of DNA Molecules in rAAV Vector Preparations by Single-stranded Virus Next-generation Sequencing.Syngeneic AAV Pseudo-particles Potentiate Gene Transduction of AAV Vectors.Obstacles and future of gene therapy for hemophilia.Practical utilization of recombinant AAV vector reference standards: focus on vector genomes titration by free ITR qPCR.A novel scalable, robust downstream process for oncolytic rat parvovirus: isoelectric point-based elimination of empty particles.CNS-restricted Transduction and CRISPR/Cas9-mediated Gene Deletion with an Engineered AAV Vector.Pharmacodynamics of anti-HIV gene therapy using viral vectors and targeted endonucleases.Regulation of RIPK1 activation by TAK1-mediated phosphorylation dictates apoptosis and necroptosis.AAV empty capsids: for better or for worse?Efficient Capsid Antigen Presentation From Adeno-Associated Virus Empty Virions In Vivo.Ultrafiltered recombinant AAV8 vector can be safely administered in vivo and efficiently transduces liver.
P2860
Q30152887-50B1D0FE-4C9A-4B3A-9DC4-E1248EA75A63Q33938435-5EE114C4-952B-4149-911A-C2544850E2BFQ36398678-8B131FE9-32BF-45AB-BD85-7101FE304A81Q36939744-92E068A9-4CEC-44F4-9DE7-0FE9B3F8FBACQ37717907-4C3A0296-9F2B-4934-9806-E1C78D89550AQ38529941-807FB5E8-1F68-4EC4-B542-BAEB56B4D925Q39680039-F2EDE0B8-9FDD-48DE-9C7D-2A81B95CF38BQ40370442-4256667E-A714-4D2E-B84E-C9E034777424Q40643280-2D872556-3949-47ED-8188-C80105B997D7Q40709550-B8C73229-2485-4294-929F-00C2B8CE1BD6Q41527499-E47121ED-41EA-417A-A252-EC621EF999F3Q42369433-5DDDBBA9-8CEA-436E-B4CE-49DC15319F33Q54221427-414D982D-7BE8-4A0B-A593-67FBFC085D64Q54241222-2FA24A4A-3F9D-4102-B158-AAD712B118F9
P2860
Empty Virions In AAV8 Vector Preparations Reduce Transduction Efficiency And May Cause Total Viral Particle Dose-Limiting Side-Effects
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Empty Virions In AAV8 Vector P ...... cle Dose-Limiting Side-Effects
@ast
Empty Virions In AAV8 Vector P ...... cle Dose-Limiting Side-Effects
@en
Empty Virions In AAV8 Vector P ...... cle Dose-Limiting Side-Effects
@nl
type
label
Empty Virions In AAV8 Vector P ...... cle Dose-Limiting Side-Effects
@ast
Empty Virions In AAV8 Vector P ...... cle Dose-Limiting Side-Effects
@en
Empty Virions In AAV8 Vector P ...... cle Dose-Limiting Side-Effects
@nl
prefLabel
Empty Virions In AAV8 Vector P ...... cle Dose-Limiting Side-Effects
@ast
Empty Virions In AAV8 Vector P ...... cle Dose-Limiting Side-Effects
@en
Empty Virions In AAV8 Vector P ...... cle Dose-Limiting Side-Effects
@nl
P2093
P2860
P356
P1476
Empty Virions In AAV8 Vector P ...... cle Dose-Limiting Side-Effects
@en
P2093
Gregory Hendricks
Guangping Gao
Junzhi Wang
Mengxin Li
Shaoyong Li
P2860
P356
10.1038/MTM.2013.9
P577
2014-01-01T00:00:00Z